Pre-Meeting Workshop: Applying Pharmacogenomics (PGx) to Clinical Practice

Registration Options

Activity Date: 02/24/2021

Registration is not configured for this course.

Session Time and Location

The live session is complete.

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Agenda

1:00-1:10 Welcome and Introductions
1:10-1:30 Clinical Relevance of PGx for Mental Health Medications
1:30-1:45 PGx Report Data
1:45-2:00 Why Pharmacists Need to Understand What is Being Tested
2:00-2:10 Break
2:10-2:30 Report Limitations and Caveats
2:30-2:50 Guidelines and Regulations
2:50-3:00 Break
3:00-4:00 PGx Case Interpretation and Practice
4:10-4:30 PGx Patient Education
4:30-4:45 Q&A

Summary

There has been significant growth in the use of pharmacogenomics (PGx) testing applied to the prescribing of psychiatric medications. Patients and providers may be unfamiliar with PGx tests, including resources available to aid in interpretation, as well as how to effectively communicate with patients and other providers about the reasons to (or not to test) and interpretation of the results. With the event of direct to consumer testing options, providers may also be uncertain of what to do when presented with a testing result, including understanding the evidence behind the results included. Furthermore, providers may not be comfortable counseling patients on PGx results due to their lack of direct experience with the tests. Therefore, this program will be geared toward the novice learner with intent to build and enhance pharmacists’ understanding of the current state of evidence for incorporating pharmacogenomics into patient care plans.

This virtual workshop is provided online using Zoom and is a live offering only. Each participant must participate real-time and needs access to a device with a webcam that supports Zoom. Successful completion and ACPE credit requires live attendance and the completion of a course evaluation. CPNP will work to provide the lecture portions of this workshop in a self-study enduring available for purchase in spring/early summer of 2021.

Course Requirements

To receive ACPE credit for the live session at the Annual Meeting, you must:

Sign in (or create a FREE account).
Register for this course.
Attend and participate in the entire session and reflect upon its teachings.
Complete the evaluation at the end of the activity.
Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

View System Requirements to Access All Session Resources

AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:

A modern web browser with JavaScript and cookies enabled: Chrome is strongly recommended, or the latest version of Firefox or Safari.
A PDF reader: Chrome built-in, Firefox built-in, Acrobat or FoxIt
An adequate device and Internet connection: Processor: Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent); Memory: 4 GB; Storage: 5 GB available; Internet speed: 4.0 Mbps (up/down)

AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.

Faculty Information

Jeffrey R. Bishop, PharmD, MS, BCPP, FCCP
Vicki L. Ellingrod, PharmD, FCCP

View biographical information

Jeffrey R. Bishop, PharmD, MS, BCPP, FCCP
Associate Professor
University of Minnesota
Minneapolis, MN

Jeffrey R. Bishop, PharmD, MS, BCPP, FCCP is associate professor in the Department of Experimental and Clinical Pharmacology at the University of Minnesota College of Pharmacy, and Adjunct Associate Professor in the Department of Psychiatry at the University of Minnesota Medical School. Dr. Bishop received his biology degree at Luther College in Decorah, Iowa. He then earned his Doctor of Pharmacy and Master’s in Clinical Investigation degrees from the University of Iowa Colleges of Pharmacy and Medicine along with a postdoctoral fellowship in clinical psychopharmacology and pharmacogenetics at the University of Iowa College of Pharmacy.

Dr. Bishop provides clinical and didactic education to pharmacy and medical trainees and maintains an active translational research program in psychopharmacology and pharmacogenomics. His research examines genetic relationships with symptom improvement, side effects, and cognitive effects of medications as well as the clinical utility of pharmacogenetic testing in mental health. Dr. Bishop is a member of the University of Minnesota Institute for Personalized Medicine as well as the University of Minnesota Precision Medicine Collaborative. He is an active member of the Clinical Pharmacogenetics Implementation Consortium with ongoing involvement in consensus guideline groups for medications used in mental health. Dr. Bishop is also active as an affiliate member of the Implementing Genomics in Practice (IGNITE) consortium pharmacogenetics interest group.

Vicki L. Ellingrod, PharmD, FCCP
Associate Dean for Research and Graduate Education, and John Gideon Searle Professor of Translational Pharmacy, College of Pharmacy, Professor of Psychiatry Medical School
University of Michigan
Ann Arbor, MI

Vicki L. Ellingrod, Pharm.D., FCCP, is the Associate Dean for Research and Graduate Education in the College of Pharmacy at the University of Michigan. She is also a professor of Psychiatry and Psychology. Within the University of Michigan, she serves as associate director of the Michigan Institute for Clinical and Health Research (MICHR), which provides training to other health professionals wanting training to do clinical research. She obtained her bachelors and PharmD from the University of Minnesota and then completed a postdoctoral fellowship in psychopharmacology/pharmacogenetics at the University of Iowa, followed by joining the faculty there as an assistant professor. Her research has focused on identification of genetic markers related to drug response in mental illness and has been funded by NIMH (National Institute of Mental Health) the FDA, and industry. Prior to joining the faculty at the University of Michigan, Dr. Ellingrod was a practicing clinical pharmacist working on the medical psychiatry unit at the University of Iowa Hospitals and Clinics. Dr. Ellingrod is a founding member of the College of Psychiatric and Neurologic Pharmacists and a full member of the American College of Neuropsychopharmacology (ACNP). She also serves as scientific editor for Pharmacotherapy and is an editor on the DiPiro text book Pharmacotherapy, a pathophysiologic approach.

No Relevant Financial Relationships to Disclose

Learning Objectives

Review current evidence behind the use of pharmacogenomics (PGx) testing for patients prescribed psychiatric and neurologic medications.
Discuss the literature regarding the genes/drug pairs commonly included on PGx tests, as well as the guidelines from Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for testing result interpretation.
Interpret PGx testing results and use results to inform therapeutic recommendations.
Demonstrate patient counseling skills regarding communication involving PGx testing.

Continuing Education Credit and Disclosures

Activity Date: 02/24/2021
ACPE Contact Hours: 3.25
ACPE Number: 0284-0000-21-001-L04-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPE The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

View disclaimer and disclosure of off-label use

Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Presentation-Specific Disclosure: My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices: Portions of the presentation will discuss pharmacogenetic information not included in drug labeling.

View fair balance and integrity statement

It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.

Education

Meeting Essentials